Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Temozolomide in Treating Patients With Anaplastic Oligodendroglioma

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
Duke University Identifier:
First received: November 1, 1999
Last updated: June 19, 2013
Last verified: October 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2001
  Estimated Primary Completion Date: No date given